
The Zacks Analyst Blog Highlights Roche, Linde, Disney and Vaso
Zacks spotlights Roche, Linde, Disney, and Vaso as analysts weigh drug demand, gas contracts, global expansion, and IT-driven resilience.
Predicted Price is the pryogiTM prediction of where the price is going in next 3-4 quarters. There may be a revision of the predicted price every 3 months from the date of publication of the first predicted price of the stock. Price on Report Date is the price of the stock on the day prediction was published by pryogiTM. Current price shows the current price of the stock.
Margin of error shows range the price will end up in dollars either above or below the predicted price. Margin of error percentage shows the price will end up in percentage either above or below the predicted price.
Expected Returns from report date shows the returns (positive or negative) from published prediction date if you bought the stock on report date. Expected Returns from today shows the returns from today if you buy the stock today. A positive expected returns indicates a profit you will make, a negative expected return indicates a loss you will make if you buy the stock. There are different strategies to apply in the stock market for profit and loss, pryogiTM will publish such strategies in the future to help you.
PryogiTM meter shows you predicted price, price on the date this prediction was published(report date) and price of the stock today on a price scale. This indicates if the stock price is moving towards or away from the predicted price
PryogiTM performance chart shows actual movement of stock price from prediction published date(report date) and if the price is moving towards or away from predicted price
Zacks spotlights Roche, Linde, Disney, and Vaso as analysts weigh drug demand, gas contracts, global expansion, and IT-driven resilience.
Roche gains from strong drug demand, Linde builds on record orders, while Disney faces TV woes and bets on global growth.
Wall Street closed sharply higher on Thursday, pulled up by materials and discretionary stocks.
Linde LIN has outperformed the market over the past 20 years by 3.43% on an annualized basis producing an average annual return of 11.99%. Currently, Linde has a market capitalization of $223.73 billion.
Linde's LIN short percent of float has fallen 4.59% since its last report. The company recently reported that it has 4.90 million shares sold short, which is 1.04% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.22 days to cover their ...
NVIDIA, Cisco, and Linde showcase AI-driven growth, strategic acquisitions, and resilient industrial leadership.
Linde LIN has outperformed the market over the past 10 years by 3.55% on an annualized basis producing an average annual return of 16.65%. Currently, Linde has a market capitalization of $227.28 billion.
International Flavors debuts POWERFRESH ACE 2000, a bread enzyme that boosts softness, extends shelf life and supports bakery sustainability goals.
Style Box ETF report for ...
IFF Q2 earnings and sales beat estimates despite y/y declines, with growth in the Taste and Food Ingredients segments.
Image source: The Motley Fool.Friday, Aug. 1, 2025, at 9 a.m. ETNeed a quote from a Motley Fool analyst? Email pr@fool.comContinue reading ...
Linde ( NASDAQ:LIN ) , a global leader in industrial gases and engineering, reported second-quarter 2025 earnings on August 1, 2025. The company delivered results ahead of market expectations, with non-GAAP earnings per share of $4.09 in Q2 2025, surpassing the analyst consensus of $4.03.
It's a rough start to the new month for Wall Street, as major U.S. stock indices plunged by midday Friday, setting the stage for a negative weekly close. SPY ETF is breaking past support. Check the chart here.
LIN's Q2 earnings and revenues increase year over year, driven by higher profits from the Americas and EMEA segments.
Linde (LIN) delivered earnings and revenue surprises of +1.49% and +1.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Ashland (ASH) delivered earnings and revenue surprises of -9.57% and -1.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
International Flavors (IFF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Macroeconomic headwinds and weaker industrial activity are likely to affect LIN's Q2 results despite support from long-term contracts.
Beyond analysts' top-and-bottom-line estimates for Linde (LIN), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Discover five unstoppable dividend stocks that could pay you for life, and why I wouldn't sell any of them!
Linde (LIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Minerals Technologies (MTX) delivered earnings and revenue surprises of +8.39% and -0.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
LIN boosts liquid oxygen and nitrogen supply with new Texas plant and Florida expansion to power U.S. rocket launches.
Linde LIN has outperformed the market over the past 20 years by 3.62% on an annualized basis producing an average annual return of 12.09%. Currently, Linde has a market capitalization of $219.91 billion.
Linde (LIN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Linde LIN has outperformed the market over the past 20 years by 3.78% on an annualized basis producing an average annual return of 12.2%. Currently, Linde has a market capitalization of $217.63 billion.
Linde LIN has outperformed the market over the past 10 years by 3.09% on an annualized basis producing an average annual return of 14.5%. Currently, Linde has a market capitalization of $219.03 billion.
LIN to invest $400M in new ASU for Blue Point's low-carbon ammonia plant, boosting its Gulf Coast clean energy presence.
Linde, Corteva, CF Industries outperformed S&P 500 with buybacks; rest of sector saw value destruction. Dow, Huntsman, Celanese lost billions in repurchase value - transparency and timing remain key. Last Chance: See the "Power Pattern" That Delivered Winners 9 Out of the Last 10 Summers.
June 13, 2025 records indicate that Representative Jonathan Jackson filed a sale of Linde LIN, valued between $65,002 and $150,000. According to the June filing, the transaction occurred on May 7, 2025. Currently, Linde shares are trading up 0.61% at $468.8.
Zacks spotlights ORCL, NVO, LIN, NVEC and CPSH for their strategic growth plays, from AI cloud to medtech sensing and advanced materials.
Linde LIN has outperformed the market over the past 20 years by 3.84% on an annualized basis producing an average annual return of 12.12%. Currently, Linde has a market capitalization of $219.11 billion.
Linde LIN has outperformed the market over the past 5 years by 3.56% on an annualized basis producing an average annual return of 18.58%. Currently, Linde has a market capitalization of $210.90 billion.
NVIDIA, Abbott Laboratories, Linde and Tredegar are part of the Zacks top Analyst ...
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp. (NVDA), Abbott Laboratories (ABT) and Linde plc (LIN), as well as a micro-cap stock Tredegar Corp. (TG).
IFF expects sales between $10.6 billion and $10.9 billion for fiscal 2025.
As May opens for business, shell-shocked stock market investors are waving goodbye to April with both hands. While the major stock indexes have bounced back moderately over the last week, stocks fell 11% at one point and declined 20% since mid-February, primarily due to tariff troubles affecting ...
LIN's first-quarter earnings gain on higher pricing and increased volumes from the Americas segment.
Linde (LIN) delivered earnings and revenue surprises of 0.51% and 1.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
International Flavors (IFF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Daqo (DQ) delivered earnings and revenue surprises of -4.90% and 36.13%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?